Featured – Discover Pharma

Welcome to Discover Pharma! Today is : January 20, 2026

Featured

European biotech,Partnerships & Funding,Research & Development,Technology and platforms
Novo Nordisk Foundation commits DKK 5.5BN (EUR 736M) to BioInnovation Institute expansion
The Novo Nordisk Foundation has committed up to DKK 5.5 [...]

January 14, 2026
Biologics & Biosimilars,Biotech,Drug Development,Precision medicine,Research & Development,Technology and platforms
Nuclera extends Series C funding to $87M to advance antibody engineering
Nuclera has extended its Series C funding to a total [...]

January 13, 2026
Biologics & Biosimilars,Biotech,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms
Argobio-backed Enodia raises €20.7 million seed to advance small-molecule protein degradation platform
Argobio Studio has announced the successful seed financing of Enodia [...]

January 12, 2026
Biotech,Central Nervous System,Clinical Development,European biotech,Regulatory Affairs
Single-cell analysis highlights molecular subgroups in endometriosis that could inform clinical trials
Endometriosis is typically treated as a single condition, yet patients [...]

January 7, 2026
CDMOs & Manufacturing,Clinical Development,Manufacturing,Market Access & Commercialization,Oncology
Symbiosis manufactures first commercial-scale batch at new Stirling facility
Symbiosis Pharmaceutical Services has completed its first commercial-scale manufacturing run [...]

January 5, 2026
Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Digital Health,Medical devices,Technology and platforms
12th Day of Christmas: Ledger Run and AcuityMD predict AI will drive operational change across clinical trials and MedTech in 2026
On the 12th Day of Christmas in Discover Pharma’s industry [...]

January 5, 2026
Artificial Intelligence,Clinical Development,Clinical Trials,Digital Health,Regulatory Affairs,Technology and platforms
11th Day of Christmas: Medable predicts agentic AI will reshape clinical trials and regulation in 2026
On the 11th Day of Christmas in Discover Pharma’s industry [...]

December 31, 2025
Drug Development,Obesity,Regulatory Affairs,Women's Health
Oushk recognised among first to meet new GPhC standards for supplying weight-loss medicines
The UK’s General Pharmaceutical Council (GPhC) has formally recognised Oushk [...]

December 29, 2025
Biotech,Market Access & Commercialization,Mergers & Acquisitions,Pharmaceuticals and therapeutics
Biopharma enters 2026 with cautious optimism as dealmaking and pipelines regain focus
The biopharmaceutical industry is heading into 2026 with renewed but [...]

December 29, 2025
Artificial Intelligence,Clinical Development,Clinical studies,Clinical Trials,Patient Centricity
Like the ten leaping Lords, PHARMASEAL takes a leap towards smarter growth in 2026
With the lords a-leaping, the industry is set to spring [...]

December 30, 2025